Provided by Tiger Trade Technology Pte. Ltd.

Cassava Sciences Inc

2.38
0.0000
Volume:- -
Turnover:- -
Market Cap:114.97M
PE:-1.08
High:2.38
Open:2.38
Low:2.38
Close:2.38
52wk High:4.98
52wk Low:1.15
Shares:48.31M
Float Shares:43.48M
Volume Ratio:- -
T/O Rate:- -
Dividend:- -
Dividend Rate:- -
EPS(TTM):-2.1976
EPS(LYR):-1.4620
ROE:-85.44%
ROA:-24.80%
PB:1.41
PE(LYR):-1.63

Loading ...

Cassava Announces Agreement to Settle Securities Class Action Litigation

GlobeNewswire
·
Dec 23, 2025

Cassava Sciences Names Dawn C. Bir to Compensation Committee

Reuters
·
Dec 23, 2025

Correction: Investors Hope for Rate Cut Following Subdued Inflation as US Futures Mixed in Friday's Premarket Session

MT Newswires Live
·
Dec 19, 2025

Stocks to Watch: Nike, Cassava Sciences, KB Home

Dow Jones
·
Dec 19, 2025

Cassava Sciences Inc - on Dec 15, FDA Places Full Clinical Hold on Cassava's Trial - SEC Filing

THOMSON REUTERS
·
Dec 19, 2025

Cassava Sciences: Not Expected to Initiate Proof-of-Concept Clinical Trial for Simufilam in Tsc-Related Epilepsy in H1 2026 as Previously Disclosed

THOMSON REUTERS
·
Dec 19, 2025

FDA Puts Cassava Sciences Simufilam Trial on Full Clinical Hold

Reuters
·
Dec 19, 2025

Cassava Sciences Awards 2025 Cash Bonuses to Top Executives

Reuters
·
Dec 18, 2025

BRIEF-Cassava Sciences Inc - FDA Requires Additional Information From Cassava For Clinical Study - SEC Filing

Reuters
·
Dec 03, 2025

Cassava Sciences Faces FDA Request for More Data on Simufilam Epilepsy Trial

Reuters
·
Dec 03, 2025

Director Robert Eugene Anderson Jr. acquires common shares of Cassava Sciences Inc

Reuters
·
Nov 26, 2025

Cassava Sciences Gains on Insider Buying

MT Newswires Live
·
Nov 26, 2025

Cassava Sciences CEO Richard Barry Acquires Common Shares

Reuters
·
Nov 25, 2025

Cassava Sciences CEO Makes Bold Move with Major Stock Purchase

TIPRANKS
·
Nov 21, 2025

Cassava Sciences CEO Richard Barry Reports Acquisition of Common Shares

Reuters
·
Nov 21, 2025

BRIEF-Cassava Sciences To Offer Securities Up To $200 Million

Reuters
·
Nov 13, 2025

Cassava Sciences Inc - Enters 'at the Market Offering' of up to $50 Mln - SEC Filing

THOMSON REUTERS
·
Nov 13, 2025

Cassava Sciences Reports Q3 2025 Financials and Advances Simufilam

TIPRANKS
·
Nov 13, 2025

Cassava Sciences Q3 net loss narrows, beats expectations

Reuters
·
Nov 12, 2025

Cassava Sciences posts Q3 net loss of $10.8 million on $106.1 million cash reserves

Reuters
·
Nov 12, 2025